Posters & Publications
Posters & Presentations
// June 12, 2025 | Presentation
CASSS CGTP Summit Rockville, MD
Optimizing Analytical Release Testing Through Reduced Volume and Turnaround Times
// June 11, 2025 | Presentation
CASSS CGTP Summit Rockville, MD
Advanced Sequencing Approaches for Comprehensive AAV Vector Characterization
// June 2, 2025 | Presentation
Cell & Gene Therapy Talk Framingham, MA
A Novel Approach to Treating Huntington’s Disease Using AAV to Deliver Gene Editing Tools to the Brain
// May 17, 2025 | Presentation
American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA
Advancing Lentiviral Vector Manufacturing: A Platform for Commercial Cell Therapy Success
// May 17, 2025 | Presentation
American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA
Broad Biodistribution and Expression of Allele Selective LETI-101 in Critical Brain Regions for Treatment of Huntington’s Disease Following Intrastriatal Delivery in NHP
// May 15, 2025 | Poster
American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA
Deep CRISPR Nuclease Portfolio and Multiple Editing Modalities Accelerates Identification of Viable Clinical Candidates
// May 15, 2025 | Poster
American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA
Peripheral Blood Mononuclear Cell (PBMC) Isolation Using Cell Fractionation Filters
// May 14, 2025 | Poster
American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA
Signature of Base Editor RNA Edits in the Transcriptome and Reduction of Exogenous RNA Editing
// May 13, 2025 | Poster
American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA
Electroporation and Lipid Nanoparticles as Delivery Methods for Targeted CRISPR/Cas9 Gene Editing in Primary Human T-Cells
// May 7, 2025 | Poster
International Society for Cell & Gene Therapy New Orleans, LA
Evaluating Buoyancy Activated Cell Sorting (BACS) for T cell Isolation in CAR-T Manufacturing
// April 7, 2025 | Presentation
CRISPR Medicines 2025 Conference Copenhagen, DK
Harnessing a diverse collection of CRISPR-associated RNA-guided nucleases and a proprietary nonviral delivery platform for precise gene editing
// February 25, 2025 | Presentation
20th Annual Huntington's Disease Therapeutics Conference Palm Springs, CA
AAV5-delivered Life Edit® CRISPR system results in broad CNS biodistribution and allele selective editing and reduction of mHTT protein in critical HD brain regions
// February 2, 2025 | Presentation
3rd Viral Vector Process Development & Manufacturing Summit Boston, MA
Novel Approach to Treating Rare Disease Using an AAV Vector to Deliver Gene Editing Tools to the Brain
// January 31, 2025 | Presentation
5th Annual Summit of Biologics Conference and Workshop on Biopharmaceutical Product Development Goa, India
Potency Development for Cell & Gene Therapy Products
// January 21, 2025 | Presentation
Phacilitate Advanced Therapies Week Dallas, Texas
Driving Innovation and Scalability In Advanced Therapies
// November 7, 2024 | Presentation
31st Annual Meeting of the Huntington Study Group Cincinnati, OH
Allele-selective editing of mHTT utilizing AAV5-delivered Life Edit®️ CRISPR System (LETI-101) results in meaningful reduction of mHTT protein
// October 24, 2024 | Presentation
Outsourced Pharma Capacity Update
How to Navigate the Successful Transition from Clinical to Commercial Manufacturing in Cell Therapy
// October 16, 2024 | Presentation
Formulation & Delivery U.S. 2024 Conference San Diego, CA
Enabling In Vivo Gene Editing with Proprietary Lipid Nanoparticles (LNPs)
// September 23-26, 2024 | Presentation
BioProcess International 2024 Boston, MA
Generation, Characterization, and Stability of iPSC Lines
// September 23-26, 2024 | Presentation
Cell and Gene Therapy International 2024 Boston, MA
Viral Design: Impact of Early Integration Across R&D and Process Development Workflows to Accelerate Development
// September 23-26, 2024 | Presentation
Cell and Gene Therapy International 2024 Boston, MA
Analytical Capabilities at ElevateBio BaseCamp Utilizing LentiPeak™
// September 17-20, 2024 | Poster
9th Annual CAR-TCR Summit Boston, MA
From Clinical Success to Commercial Readiness
// August 19-22, 2024 | Poster
16TH Annual Bioprocessing Summit Boston, MA
Rapid Development of Ion Exchange Chromatography for Full/Empty Separation in Adeno-Associated Virus Serotype 5
// August 19-22, 2024 | Poster
16TH Annual Bioprocessing Summit Boston, MA
Evaluation of Alternative Process Cell Lysis Reagents as Replacements for Triton X-100 for AAV Production
// July 25, 2024 | Presentation
Outsourced Pharma Capacity Update
LentiPeak™️ Plug and Play Capabilities for a Lentiviral Vector Platform Process
// July 9, 2024 | Presentation
Global Cell & Gene Therapy Summit Boston, MA
Low Volume Wash, Formulation and Fill Strategies for T Cell Therapies
// June 13, 2024 | Presentation
CASSS Cell & Gene Therapy Products Symposium 2024 Rockville, MD
Balancing Flexibility and Standardization of AAV Manufacturing Processes
// June 12, 2024 | Presentation
CASSS Cell & Gene Therapy Products Symposium 2024 Rockville, MD
Potency Development for an In Vivo AAV Gene Editing Therapy
// May 2024 | Presentation
Outsourced Pharma
Phase Appropriate Potency Strategy Using Analytical Capabilities at BaseCamp
// May 10, 2024 | Poster
American Society of Gene and Cell Therapy’s (ASGCT) 27th Annual Meeting Baltimore, MD
Development and Scale Up of a Robust End-to-End Manufacturing Process for High Quality AAV Production
// May 10, 2024 | Poster
American Society of Gene and Cell Therapy’s (ASGCT) 27th Annual Meeting Baltimore, MD
A Rapid and Scalable 96-Well Platform to Screen CARs and TCRs
// May 10, 2024 | Poster
American Society of Gene and Cell Therapy’s (ASGCT) 27th Annual Meeting Baltimore, MD
Early Characterization of Research-Grade AAV6 Productions Allows for Manufacturing Alignment During Candidate Nomination
// May 10, 2024 | Poster
American Society of Gene and Cell Therapy’s (ASGCT) 27th Annual Meeting Baltimore, MD
Design and Production of Circular RNAs (circRNAs) with Validated Functional Activity in Cell Models
// February 26, 2024 | Poster
CHDI’s 19th Annual Huntington’s Disease Therapeutics Conference Palm Springs, CA
Allele Selective SNP Editing Utilizing AAV5-delivered Life Edit® Nuclease and guide RNA Resulting in Meaningful Reduction of mutant HTT Protein
// October 12, 2023 | Presentation
Cell & Gene Therapy Manufacturing & Commercialization US Conference Boston, MA
Charting a Resilient Path Forward: Future Proofing the Cell and Gene Therapy Supply Chain
// October 6, 2023 | Presentation
Cell & Gene with Outsourced Pharma - Virtual Webinar
ElevateBio Capacity Update October 2023
// September 20, 2023 | Poster
Cell & Gene Therapy Manufacturing & Commercialization US Conference Boston, MA
Optimization of Nuclease Treatment for Removal of Residual DNAs in Adeno-Associated Viruses
// September 8, 2023 | Poster
International Society for Cell & Gene Therapy Houston, TX
Development of a Proprietary HEK293 Suspension Cell Line for Robust rAAV and LVV Production
// August 17, 2023 | Poster
Genome Engineering: CRISPR Frontiers Conference Cold Spring Harbor, NY
Utilizing PAM diversity for allele-specific knockdown of mut-HTT in vivo
// August 16, 2023 | Poster
15th Annual Bioprocessing Summit Boston, MA
Development and Optimization of a Scalable Affinity Purification of Adeno Associated Virus Serotype 6
// May 19, 2023 | Poster
The American Society of Gene and Cell Therapy’s (ASGCT) 26th Annual Meeting
Optimization of Nuclease Digestion Unit Operation in a Lentiviral Vector Process for Increased Reduction of DNA Impurities
// May 19, 2023 | Poster
The American Society of Gene and Cell Therapy’s (ASGCT) 26th Annual Meeting
Promoter Triage & PRE Triage for Gene Expression & Function Optimization
// May 18, 2023 | Poster
The American Society of Gene and Cell Therapy’s (ASGCT) 26th Annual Meeting
A Robust and Scalable Research Grade Platform Process for AAV6 Production and Purification
// May 17, 2023 | Poster
The American Society of Gene and Cell Therapy’s (ASGCT) 26th Annual Meeting
Upstream Optimization Paved a Straightforward Path for High Percentage of Full Capsids in AAV6
// April 25, 2023 | Presentation
18th Annual Huntington's Disease Therapeutics Conference Dubrovnik, Croatia
Allele-selective SNP editing utilizing AAV5-delivered Life Edit® nuclease and guide RNA resulting in meaningful reduction of mutant HTT protein
// April 25, 2023 | Poster
18th Annual Huntington's Disease Therapeutics Conference Dubrovnik, Croatia
Mutant and wildtype huntingtin protein quantitation utilizing automated capillary electrophoresis
// April 25, 2023 | Poster
18th Annual Huntington's Disease Therapeutics Conference Dubrovnik, Croatia
Allele Selective SNP Editing Utilizing AAV5-delivered Life Edit® Nuclease and guide RNA Resulting in Meaningful Reduction of mutant HTT Protein
// September 27, 2022 | Poster
BioProcess International
A Scalable and Robust Lentiviral Platform for GMP Manufacturing
// June 12, 2022 | Poster
CRISPR 2022
Compact RNA-guided nucleases from nonpathogenic soil microbes provide new tools for efficient and robust editing in human cells
// May 3, 2022 | Poster
The American Society of Gene & Cell Therapy (ASGCT)
A Robust and Scalable Platform Process for GMP Manufacturing of Lentiviral Vectors
Publications
// February 4, 2025 | Cell & Gene
Accelerating Innovative Cell Therapy Development Through Phase-Appropriate Potency Control
Deb Bhattacharya, Ph.D. and Cindy Riggins, Ph.D.
// May 23, 2024 | Cell and Gene Therapy
Outsourced Pharma Capacity Update May 2024
Debaditya Bhattacharya, Ph.D. VP, Analytical Development and Miranda Williams Scientist I, Analytical Development discuss BaseCamp’s analytical capabilities and more in a recorded webcast.
// February 28, 2023 | The Long Run
A Life in Biotech & the Cell Therapy Wave: David Hallal on The Long Run
This episode was recorded in person at the JP Morgan Healthcare Conference in San Francisco. Biotech history buffs will especially enjoy the first half, where he talks about what pharmaceutical sales was like and what it was like to work at Amgen in the early days.
// October 12, 2022 | Biotech 2050 Podcast
A New Vision for Cell and Gene Therapy, Andrew Sandford & Michael Paglia, ElevateBio BaseCamp
Andrew Sandford and Michael Paglia are the President and COO, respectively, of ElevateBio BaseCamp, a cell and gene therapy technology company powering transformative therapies. They join us from the company’s manufacturing facilities in Waltham, Massachusetts, for a discussion about the landscape of company creation in the cell and gene therapy space and how ElevateBio is helping companies bring innovation and therapeutics to clinics and patients to help treat and cure diseases.
// July 12, 2022 | Ori Spotlight
Mike Paglia – Chief Operating Officer, ElevateBio
Mike Paglia, COO BaseCamp, on ‘Ori Spotlight’ podcast discussing how Elevate supports the cell and gene therapy industry, the long-term benefits of digital manufacturing processes, and the importance of removing the cost barrier to CGTs.
// March 22, 2022 | Accelerating Clinical Podcast
The Power of Collective Wisdom
Amit Mathur, CIO ElevateBio, on ‘Accelerating Clinical’ podcast, discussing the power of collective wisdom
// February 22, 2022 | Cell & Gene Therapy Insights
Banking on the future of regenerative medicine with cGMP-compliant iPSC lines
Melissa Carpenter, pHD, CSO Regenerative Medicine
// January 18, 2022 | American Builders Quarterly
Mario Miele Begins with the End in Mind
Mario Miele, VP Facilities and Engineering, article discussing the buildout of BaseCamp
